Amedisys Home Health in Grove, OK - Home Health Agency

Amedisys Home Health is a medicare certified home health care agency in Grove, Oklahoma. It is located in Grove at 1637 S Main Street, Grove, Oklahoma 74344. You can reach out to the office of Amedisys Home Health via phone at (918) 787-9496. Amedisys Home Health provide healthcare services in Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Home Health Aide. It has the following ownership type - Proprietary.

Amedisys Home Health is certified by CMS (Centers for Medicare & Medicaid Services) and participates in medicare program. This means if you are part of medicare program, you may consider this home health facility for your medical needs. The medicare CCN number for Amedisys Home Health is 377072 and it was first certified by CMS in 1984 (40 years certified).

Contact Information

Amedisys Home Health
1637 S Main Street, Grove, Oklahoma 74344
(918) 787-9496


Home Healthcare Agency Profile

NameAmedisys Home Health
Location1637 S Main Street, Grove, Oklahoma
Certified ByMedicare
Services OfferedNursing Care
Physical Therapy
Occupational Therapy
Speech Pathology
Medical Social Services
Home Health Aide
Medicare ID377072
Ownership TypeProprietary
Service Area Zip Codes74301, 74331, 74333, 74338, 74339, 74340, 74342, 74343, 74344, 74345, 74346, 74347, 74349, 74350, 74354, 74358, 74363, 74366, 74369, 74370

NPI for Amedisys Home Health:

Home Healthcare Agencies may have multiple NPI numbers. We have found possible NPI number/s associated with Amedisys Home Health from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1417905175
Organization NameAMEDISYS OKLAHOMA, LLC
Doing Business AsAMEDISYS HOME HEALTH
Address1637 S Main St, Grove, OK 74344
Phone Number918-787-9496

News Archive

FDA notifies PDUFA action date for Cell Therapeutics' NDA for pixantrone

Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has notified CTI that a Prescription Drug User Fee Act (PDUFA) action date of April 23, 2010 under standard review has been established regarding CTI's NDA for pixantrone as potential treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL).

Motor neurone disease neck collars: an interview with Dr Christopher J McDermott, Clinical Senior Lecturer, University of Sheffield

The majority of the current neck support collars for MND patients were designed for a different purpose. So, if you think about when people are involved in a road traffic accident, the paramedics arrive and put a collar on to immobilize the neck and protect the spine. A lot of the collars that we give to our patients with MND were actually designed for that purpose - to immobilize the necks of people involved in trauma… and patients don't want that.

Majority of nurses experience workplace violence

Three-quarters of nurses providing private and public care experienced workplace violence, but only one in six incidents were formally reported, according to study published in the February issue of the Journal of Clinical Nursing.

First patient treated in cytomegalovirus~ACE/ASPECT Phase II randomised clinical trial

Cell Medica, a leading UK cellular therapeutics company that develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, announces today that the first patient has been treated in the CMV~ACE/ASPECT trial at University College Hospital London.

MU researcher gets $1 million from CDC to enhance FASDs prevention efforts

Fetal Alcohol Spectrum Disorders (FASDs), like Autism Spectrum Disorders, manifest in childhood as physical abnormalities along with social, attention and learning difficulties that range in severity and continue into adulthood.

Read more Medical News

› Verified 1 days ago

Quality Ratings:

Amedisys Home Health is "Medicare-certified" which means that this home health agency is approved by Medicare and meets certain federal health and safety requirements, however, home health agencies may vary in the quality of care and services they provide to their patients. The quality ratings gives you an indication of the care Amedisys Home Health give to their patients incomparison to other home health agencies. This quality rating is based on process quality measures and patient outcome measures survey conducted by CMS.

Quality Rating:

News Archive

FDA notifies PDUFA action date for Cell Therapeutics' NDA for pixantrone

Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has notified CTI that a Prescription Drug User Fee Act (PDUFA) action date of April 23, 2010 under standard review has been established regarding CTI's NDA for pixantrone as potential treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL).

Motor neurone disease neck collars: an interview with Dr Christopher J McDermott, Clinical Senior Lecturer, University of Sheffield

The majority of the current neck support collars for MND patients were designed for a different purpose. So, if you think about when people are involved in a road traffic accident, the paramedics arrive and put a collar on to immobilize the neck and protect the spine. A lot of the collars that we give to our patients with MND were actually designed for that purpose - to immobilize the necks of people involved in trauma… and patients don't want that.

Majority of nurses experience workplace violence

Three-quarters of nurses providing private and public care experienced workplace violence, but only one in six incidents were formally reported, according to study published in the February issue of the Journal of Clinical Nursing.

First patient treated in cytomegalovirus~ACE/ASPECT Phase II randomised clinical trial

Cell Medica, a leading UK cellular therapeutics company that develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, announces today that the first patient has been treated in the CMV~ACE/ASPECT trial at University College Hospital London.

MU researcher gets $1 million from CDC to enhance FASDs prevention efforts

Fetal Alcohol Spectrum Disorders (FASDs), like Autism Spectrum Disorders, manifest in childhood as physical abnormalities along with social, attention and learning difficulties that range in severity and continue into adulthood.

Read more Medical News

› Verified 1 days ago

Process Quality Measures:

The below quality measures show how often Amedisys Home Health used best practices when caring for its patients (process measures). Amedisys Home Health quality data is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Quality MeasureProviderNational Avg.
How often the home health team began their patients’ care in a timely manner99.895.7
How often the home health team taught patients (or their family caregivers) about their drugs10098.6
How often the home health team checked patients’ risk of falling99.899.6
How often the home health team checked patients for depression89.797.4
How often the home health team made sure that their patients have received a flu shot for the current flu season.96.678.7
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot).97.582.2
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care99.596.4

News Archive

FDA notifies PDUFA action date for Cell Therapeutics' NDA for pixantrone

Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has notified CTI that a Prescription Drug User Fee Act (PDUFA) action date of April 23, 2010 under standard review has been established regarding CTI's NDA for pixantrone as potential treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL).

Motor neurone disease neck collars: an interview with Dr Christopher J McDermott, Clinical Senior Lecturer, University of Sheffield

The majority of the current neck support collars for MND patients were designed for a different purpose. So, if you think about when people are involved in a road traffic accident, the paramedics arrive and put a collar on to immobilize the neck and protect the spine. A lot of the collars that we give to our patients with MND were actually designed for that purpose - to immobilize the necks of people involved in trauma… and patients don't want that.

Majority of nurses experience workplace violence

Three-quarters of nurses providing private and public care experienced workplace violence, but only one in six incidents were formally reported, according to study published in the February issue of the Journal of Clinical Nursing.

First patient treated in cytomegalovirus~ACE/ASPECT Phase II randomised clinical trial

Cell Medica, a leading UK cellular therapeutics company that develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, announces today that the first patient has been treated in the CMV~ACE/ASPECT trial at University College Hospital London.

MU researcher gets $1 million from CDC to enhance FASDs prevention efforts

Fetal Alcohol Spectrum Disorders (FASDs), like Autism Spectrum Disorders, manifest in childhood as physical abnormalities along with social, attention and learning difficulties that range in severity and continue into adulthood.

Read more Medical News

› Verified 1 days ago

Patient Outcome Quality Measures:

The below quality measures show whether patients with Amedisys Home Health improved in certain important areas of care (patient outcome). Amedisys Home Health quality data is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Quality MeasureProviderNational Avg.
How often patients got better at walking or moving around81.979.6
How often patients got better at getting in and out of bed85.681.1
How often patients got better at bathing94.682.3
How often patients’ breathing improved90.182.8
How often patients’ wounds improved or healed after an operation86.592.3
How often patients got better at taking their drugs correctly by mouth81.575
How often home health patients had to be admitted to the hospital15.115.4
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted19.313
How often physician-recommended actions to address medication issues were completely timely99.494

News Archive

FDA notifies PDUFA action date for Cell Therapeutics' NDA for pixantrone

Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has notified CTI that a Prescription Drug User Fee Act (PDUFA) action date of April 23, 2010 under standard review has been established regarding CTI's NDA for pixantrone as potential treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL).

Motor neurone disease neck collars: an interview with Dr Christopher J McDermott, Clinical Senior Lecturer, University of Sheffield

The majority of the current neck support collars for MND patients were designed for a different purpose. So, if you think about when people are involved in a road traffic accident, the paramedics arrive and put a collar on to immobilize the neck and protect the spine. A lot of the collars that we give to our patients with MND were actually designed for that purpose - to immobilize the necks of people involved in trauma… and patients don't want that.

Majority of nurses experience workplace violence

Three-quarters of nurses providing private and public care experienced workplace violence, but only one in six incidents were formally reported, according to study published in the February issue of the Journal of Clinical Nursing.

First patient treated in cytomegalovirus~ACE/ASPECT Phase II randomised clinical trial

Cell Medica, a leading UK cellular therapeutics company that develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, announces today that the first patient has been treated in the CMV~ACE/ASPECT trial at University College Hospital London.

MU researcher gets $1 million from CDC to enhance FASDs prevention efforts

Fetal Alcohol Spectrum Disorders (FASDs), like Autism Spectrum Disorders, manifest in childhood as physical abnormalities along with social, attention and learning difficulties that range in severity and continue into adulthood.

Read more Medical News

› Verified 1 days ago

Patients' Survey and Ratings:

The patient experience of care survey collects patient (or their family or friend's) feedback about topics for which the patient is the best source of information. When choosing a home health agency, patients can use this information to find out what other patients thought about the care given by a certain home health agency. The total number of patients who responded in this survey for Amedisys Home Health are 121.
Question Type:Rating by Patients
Health team gave care in a professional way
Health team communicated well with them
Health team discussed medicines, pain, and home safety
How patients rated overall care from agency

News Archive

FDA notifies PDUFA action date for Cell Therapeutics' NDA for pixantrone

Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has notified CTI that a Prescription Drug User Fee Act (PDUFA) action date of April 23, 2010 under standard review has been established regarding CTI's NDA for pixantrone as potential treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL).

Motor neurone disease neck collars: an interview with Dr Christopher J McDermott, Clinical Senior Lecturer, University of Sheffield

The majority of the current neck support collars for MND patients were designed for a different purpose. So, if you think about when people are involved in a road traffic accident, the paramedics arrive and put a collar on to immobilize the neck and protect the spine. A lot of the collars that we give to our patients with MND were actually designed for that purpose - to immobilize the necks of people involved in trauma… and patients don't want that.

Majority of nurses experience workplace violence

Three-quarters of nurses providing private and public care experienced workplace violence, but only one in six incidents were formally reported, according to study published in the February issue of the Journal of Clinical Nursing.

First patient treated in cytomegalovirus~ACE/ASPECT Phase II randomised clinical trial

Cell Medica, a leading UK cellular therapeutics company that develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, announces today that the first patient has been treated in the CMV~ACE/ASPECT trial at University College Hospital London.

MU researcher gets $1 million from CDC to enhance FASDs prevention efforts

Fetal Alcohol Spectrum Disorders (FASDs), like Autism Spectrum Disorders, manifest in childhood as physical abnormalities along with social, attention and learning difficulties that range in severity and continue into adulthood.

Read more Medical News

› Verified 1 days ago

The patient survey data of Amedisys Home Health is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience MeasureProviderNational Avg.
Percent of patients who reported that their home health team gave care in a professional way8788
Percent of patients who reported that their home health team communicated well with them8685
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them8583
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest)9084
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family8178

News Archive

FDA notifies PDUFA action date for Cell Therapeutics' NDA for pixantrone

Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has notified CTI that a Prescription Drug User Fee Act (PDUFA) action date of April 23, 2010 under standard review has been established regarding CTI's NDA for pixantrone as potential treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL).

Motor neurone disease neck collars: an interview with Dr Christopher J McDermott, Clinical Senior Lecturer, University of Sheffield

The majority of the current neck support collars for MND patients were designed for a different purpose. So, if you think about when people are involved in a road traffic accident, the paramedics arrive and put a collar on to immobilize the neck and protect the spine. A lot of the collars that we give to our patients with MND were actually designed for that purpose - to immobilize the necks of people involved in trauma… and patients don't want that.

Majority of nurses experience workplace violence

Three-quarters of nurses providing private and public care experienced workplace violence, but only one in six incidents were formally reported, according to study published in the February issue of the Journal of Clinical Nursing.

First patient treated in cytomegalovirus~ACE/ASPECT Phase II randomised clinical trial

Cell Medica, a leading UK cellular therapeutics company that develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, announces today that the first patient has been treated in the CMV~ACE/ASPECT trial at University College Hospital London.

MU researcher gets $1 million from CDC to enhance FASDs prevention efforts

Fetal Alcohol Spectrum Disorders (FASDs), like Autism Spectrum Disorders, manifest in childhood as physical abnormalities along with social, attention and learning difficulties that range in severity and continue into adulthood.

Read more News

› Verified 1 days ago

Home Healthcare Agencies in Grove, OK

Amedisys Home Health
Location: 1637 S Main Street, Grove, Oklahoma 74344
Ratings:

Phone: (918) 787-9496    
Integris Home Care Grove
Location: 2229 South Main Street, Grove, Oklahoma 74344
Ratings:

Phone: (918) 786-4461    

Home Health Care

Home health care is a wide range of health care services that can be given in your home for an illness or injury. Home health care is usually less expensive, more convenient, and just as effective as care you get in a hospital or skilled nursing facility (SNF). The goal of home health care is to treat an illness or injury. Home health care helps you get better, regain your independence, and become as self-sufficient as possible.

Home Healthcare Agency Compare

Home Health Compare has information about the quality of care provided by "Medicare-certified" home health agencies throughout the nation. "Medicare-certified" means the home health agency is approved by Medicare and meets certain federal health and safety requirements. Home Health Compare can help you or your family or friends choose a quality home health agency that has the skilled home health services you need.

Home Health Compare was created through the efforts of the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services (DHHS).

NOTE: Medicare won't cover home health services provided by a home health agency that hasn't been Medicare-certified.

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.